Scynexis Inc
SCYX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001178253
No open-market purchases or sales by Scynexis Inc insiders were filed in the last 90 days; 40 institutions reported holding it in 13F filings for Q2 2026, worth $21.0M in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Scynexis Inc changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 46 | 47 | +1 |
| Shares | 15.0M | 14.1M | −975.1K (−6.5%) |
| Value | $91.7M | $54.9M | −$36.8M (−40.1%) |
New holders (6)
Institutions that held Scynexis Inc at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Decheng Capital Management III (Cayman), LLC | 555,555 | $2.17M | 0.67% |
| Millennium Management LLC | 45,079 | $176.0K | 0.00% |
| Citigroup Inc | 6,559 | $26.0K | 0.00% |
| JPMorgan Chase & Co | 4,278 | $17.0K | 0.00% |
| Northwestern Mutual Wealth Management Co | 990 | $4.00K | 0.00% |
| Prospera Financial Services Inc | 619 | $2.00K | 0.00% |
Sold out (5)
Institutions that held Scynexis Inc at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Empery Asset Management, LP | 43,294 | $264.0K |
| Virtu Financial LLC | 14,610 | $89.0K |
| Raymond James & Associates | 12,093 | $74.0K |
| UBS Group AG | 2,476 | $15.0K |
| Signet Financial Management, LLC | 1,680 | $10.0K |